Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ikaria Inc.

Headquarters: Hampton, NJ, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired

BioCentury | Feb 23, 2022
Product Development

Feb. 22 Quick Takes: Enhertu meets mark in breast cancer subgroup

Plus updates from BeiGene, Takeda, Code, Kiniksa, Hangzhou, Homology and more
BioCentury | Aug 15, 2019
Clinical News

At last, a win for terlipressin -- and Mallinckrodt

BioCentury | Aug 22, 2016
Clinical News

Lucassin terlipressin: Phase III started

BioCentury | May 30, 2016
Finance

It takes a village

How VC 5AM will avoid strikeouts with its new early stage biotech fund
BioCentury | Sep 14, 2015
Finance

Periodic piece

Why Arch is again backing elemental reducing agents
BioCentury | Jul 28, 2015
Clinical News

Bellerophon plummets on BCM data

BioCentury | Jul 28, 2015
Company News

Management tracks

BioCentury | Jul 21, 2015
Company News

Management tracks

BioCentury | May 25, 2015
Company News

Ikaria, Mallinckrodt deal

Items per page:
1 - 10 of 62